IP Library Granted Patent US 11,767,557
Granted Patent B2
US 11,767,557 · App. 16/213,551 · Granted Sep 26, 2023

Single cell analyses

Inventors: J. Christopher Love (Somerville, MA); Todd Michael Gierahn (Brookline, MA); Alexander K. Shalek (Lexington, MA); Marc Havens Wadsworth (Somerville, MA); Travis K. Hughes (Cambridge, MA)
Assignee: Massachusetts Institute of Technology
C12Q1/6874B01L3/5085C12N15/1068C12N15/1093C12N15/1096C12Q1/6806G03F7/2014B01L2200/0647B01L2300/0681B01L2300/0819B01L2300/0829B01L2300/0851
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,767,557
App. No.
16/213,551
Filed
Dec 7, 2018
Granted
Sep 26, 2023
Kind
B2
Art Unit
1675
USPC
506/16
Abstract

Modifications to both hardware and enzymatic reactions used in single cell analyses such as but not limited to Seq-well that enable significant increases in the yield of transcripts per cell, portability and ease of use, increased scalability of the assay, and linkage of transcript information to other measurements made in the picowell arrays are disclosed.

Claims (23)

1. A method for producing a library of nucleic acids containing universal primer sites on the 5′ and 3′ end from input nucleic acids comprising:

(a) providing a picowell array comprising a plurality of picowells,

(b) contacting input nucleic acids with a pool of capture oligonucleotides in a picowell of the plurality of picowells, each capture oligonucleotide in the picowell containing a 5′ universal primer site and a 3′ target binding site complementary to a nucleotide sequence in an input nucleic acid, wherein the input nucleic acids comprise RNA, and wherein the 3′ target binding site contained in the capture oligonucleotide comprises a poly(dT) sequence,

(c) adding a DNA polymerase and thereby extending the capture oligonucleotides hybridized to the input nucleic acids, to form first strand cDNA nucleic acids each comprising the 5′ universal primer site and a sequence that is complementary to one of the input nucleic acids,

(d) contacting the first strand cDNA nucleic acids with a pool of second strand priming oligonucleotides, each consisting of a 5′ universal primer site and a 3′ target binding site complementary to a nucleotide sequence in the first strand cDNA nucleic acid, wherein each 3′ target binding site of the second strand priming oligonucleotides consists of a random sequence,

(e) adding a DNA polymerase and thereby extending the second strand priming oligonucleotides, to form second strand cDNA nucleic acids comprising 5′ and 3′ universal primer sites that flank nucleotide sequences present in the input nucleic acids, and

(f) amplifying the second strand cDNA nucleic acids comprising 5′ and 3′ universal primer sites formed in step (e).

2. The method of claim 1 , wherein each capture oligonucleotide comprises a barcode present between the 5′ universal primer site and the 3′ target binding site.

3. The method of claim 1 , wherein the capture oligonucleotides are attached to a surface of a bead.

4. The method of claim 1 , wherein the input nucleic acids are derived from a single cell.

5. The method of claim 1 , wherein a crowding reagent is added in step (b), (c), (d) and/or (e).

6. The method of claim 1 , wherein the random sequence in the 3′ target binding site of the second strand priming oligonucleotide is 7, 8, 9, 10, 11, 12, 13, 14, or 15 nucleotides long.

7. The method of claim 1 , further comprising pooling the content of a plurality of picowells into a single reaction volume after (b).

8. The method of claim 7 , wherein (d) and (e) are performed in the single reaction volume.

9. The method of claim 7 , wherein (c) is performed in the single reaction volume.

10. The method of claim 1 , wherein the DNA polymerase added in (e) lacks both 5′-3′ and 3′-5′ exonuclease activity.

11. The method of claim 4 , wherein the method further comprises loading the single cell to the picowell array, and wherein each picowell of the plurality of picowells comprises a functionalized surface comprising one or more nucleic acid barcodes.

12. The method of claim 11 , wherein each nucleic acid barcode is unique relative to all other nucleic acid barcodes in the array or to a subset of other nucleic acid barcodes in the array.

13. The method of claim 11 , wherein the location of each nucleic acid barcode in the array is known.

14. The method of claim 3 , wherein each of the capture oligonucleotides in the picowell further comprises a bead barcode that is the same in each capture oligonucleotide of the picowell.

15. The method of claim 14 , wherein the bead barcode identically labels the input nucleic acids derived from the same single cell.

16. The method of claim 3 , further comprising separating the second strand cDNA nucleic acids by base-mediated DNA denaturation.

17. The method of claim 1 , wherein the amplifying comprises PCR amplification.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 20, 2021
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 057541/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2019
From: LOVE, J. CHRISTOPHER; GIERAHN, TODD MICHAEL; SHALEK, ALEXANDER K.; WADSWORTH, MARC HAVENS; HUGHES, TRAVIS K.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 048729/0138 →
Continuity (2)
Provisional Application 62595895 · Dec 7, 2017
Related Publication 20190218607A1 · Jul 18, 2019
Cited By (5)
US 12,529,094 US 12,566,114 US 12,630,818 US 12,668,835 US 12,723,982